FI892016L - Förfarande för framställning av nya, terapeutiskt användbara, eventuellt -substituerade 4-(kinolin-2-ylmetoxi)-fenylättiksyror och -estrar - Google Patents

Förfarande för framställning av nya, terapeutiskt användbara, eventuellt -substituerade 4-(kinolin-2-ylmetoxi)-fenylättiksyror och -estrar Download PDF

Info

Publication number
FI892016L
FI892016L FI892016A FI892016A FI892016L FI 892016 L FI892016 L FI 892016L FI 892016 A FI892016 A FI 892016A FI 892016 A FI892016 A FI 892016A FI 892016 L FI892016 L FI 892016L
Authority
FI
Finland
Prior art keywords
quinolin
methoxy
esters
novel
preparation
Prior art date
Application number
FI892016A
Other languages
English (en)
Finnish (fi)
Other versions
FI892016A0 (sv
FI91855B (sv
FI91855C (sv
Inventor
Klaus Mohrs
Siegfried Raddatz
Romanis Fruchtmann
Christian Kohlsdorfer
Reiner Mueller-Peddinghaus
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI892016A0 publication Critical patent/FI892016A0/sv
Publication of FI892016L publication Critical patent/FI892016L/sv
Publication of FI91855B publication Critical patent/FI91855B/sv
Application granted granted Critical
Publication of FI91855C publication Critical patent/FI91855C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI892016A 1988-04-29 1989-04-27 Förfarande för framställning av nya, terapeutiskt användbara, eventuellt -substituerade 4-(kinolin-2-ylmetoxi)-fenylättiksyror och -estrar FI91855C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3814504A DE3814504A1 (de) 1988-04-29 1988-04-29 (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3814504 1988-04-29

Publications (4)

Publication Number Publication Date
FI892016A0 FI892016A0 (sv) 1989-04-27
FI892016L true FI892016L (sv) 1989-10-30
FI91855B FI91855B (sv) 1994-05-13
FI91855C FI91855C (sv) 1994-08-25

Family

ID=6353182

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892016A FI91855C (sv) 1988-04-29 1989-04-27 Förfarande för framställning av nya, terapeutiskt användbara, eventuellt -substituerade 4-(kinolin-2-ylmetoxi)-fenylättiksyror och -estrar

Country Status (20)

Country Link
US (1) US4929626A (sv)
EP (1) EP0339416B1 (sv)
JP (1) JPH01313466A (sv)
KR (1) KR900016136A (sv)
CN (1) CN1027068C (sv)
AT (1) ATE89819T1 (sv)
AU (1) AU614358B2 (sv)
CA (1) CA1333803C (sv)
DD (1) DD283811A5 (sv)
DE (2) DE3814504A1 (sv)
DK (1) DK168009B1 (sv)
ES (1) ES2054919T3 (sv)
FI (1) FI91855C (sv)
HU (1) HU205079B (sv)
IE (1) IE62888B1 (sv)
IL (1) IL90052A (sv)
NO (1) NO175149C (sv)
NZ (1) NZ228899A (sv)
PT (1) PT90382B (sv)
ZA (1) ZA893171B (sv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3632329A1 (de) * 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5232916A (en) * 1988-06-27 1993-08-03 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
US5102881A (en) * 1988-06-27 1992-04-07 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
US5194438A (en) * 1988-07-15 1993-03-16 Basf Aktiengesellschaft α-arylacrylates substituted by a trifluoromethylpyrimidinyloxy radical, fungicidal compositions and methods
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
US5071988A (en) * 1989-10-27 1991-12-10 American Home Products Corporation Substituted benzoylbenzene-, biphenyl- and 2-oxazole-alkanoic acid derivatives
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5254581A (en) * 1990-06-21 1993-10-19 Imperial Chemical Industries Plc Pyran derivatives and their use as inhibitors of 5-lipoxygenase
US4996214A (en) * 1990-06-28 1991-02-26 Smithkline Beecham Corporation Quinolinyl substituted phenyl/thioalkanoic acid substituted propionic acids and leucotriene antagonist use thereof
US5187180A (en) * 1990-07-26 1993-02-16 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
US5221678A (en) * 1990-07-26 1993-06-22 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
US5266568A (en) * 1990-10-12 1993-11-30 Merck Frosst Canada, Inc. Hydroxyalkylquinoline ether acids as leukotriene antagonists
US5856322A (en) * 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
DE4139751A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
EP0540165A1 (en) * 1991-10-03 1993-05-05 Zeneca Limited Alkanoic acid derivatives
DE4139750A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
DE4226519A1 (de) * 1992-08-11 1994-02-17 Bayer Ag 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate
ES2061406B1 (es) * 1993-05-07 1995-06-01 Uriach & Cia Sa J Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
DE4443891A1 (de) * 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
WO2008067566A1 (en) 2006-11-30 2008-06-05 Amira Pharmaceuticals, Inc. Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
ES2878405T3 (es) 2014-02-04 2021-11-18 Bioscience Pharma Partners Llc Uso de inhibidores de flap para reducir la lesión mediada por neuroinflamación en el sistema nervioso central

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
JPH0729952B2 (ja) * 1984-10-30 1995-04-05 ユ−エスヴイ− フア−マシユ−テイカル コ−ポレ−シヨン 抗炎症及び抗アレルギ−化合物
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
US4642347A (en) * 1985-05-21 1987-02-10 American Home Products Corporation 3(2-quinolinylalkoxy)phenols
US4661499A (en) * 1985-06-18 1987-04-28 Merck Frosst Canada, Inc. 2-[(substituted)-phenoxymethyl]quinolines

Also Published As

Publication number Publication date
DE3814504A1 (de) 1989-11-09
EP0339416B1 (de) 1993-05-26
NO175149B (no) 1994-05-30
HU205079B (en) 1992-03-30
NO175149C (no) 1994-09-07
DD283811A5 (de) 1990-10-24
NZ228899A (en) 1991-06-25
FI892016A0 (sv) 1989-04-27
IL90052A0 (en) 1989-12-15
DE58904459D1 (de) 1993-07-01
HUT50779A (en) 1990-03-28
PT90382A (pt) 1989-11-10
DK208789D0 (da) 1989-04-28
JPH01313466A (ja) 1989-12-18
CN1027068C (zh) 1994-12-21
PT90382B (pt) 1994-09-30
CN1045777A (zh) 1990-10-03
ES2054919T3 (es) 1994-08-16
NO891523D0 (no) 1989-04-13
AU3385289A (en) 1989-11-02
DK208789A (da) 1989-10-30
CA1333803C (en) 1995-01-03
EP0339416A1 (de) 1989-11-02
NO891523L (no) 1989-10-30
US4929626A (en) 1990-05-29
AU614358B2 (en) 1991-08-29
FI91855B (sv) 1994-05-13
FI91855C (sv) 1994-08-25
ATE89819T1 (de) 1993-06-15
IL90052A (en) 1993-07-08
DK168009B1 (da) 1994-01-17
ZA893171B (en) 1989-12-27
KR900016136A (ko) 1990-11-12
IE62888B1 (en) 1995-03-08
IE891402L (en) 1989-10-29

Similar Documents

Publication Publication Date Title
FI892016L (sv) Förfarande för framställning av nya, terapeutiskt användbara, eventuellt -substituerade 4-(kinolin-2-ylmetoxi)-fenylättiksyror och -estrar
FI894477A7 (sv) Förfarande för framställning av terapeutiskt aktiva 7-substituerade 3,5-dihydroxihept-6-ynsyror och deras derivat samt som mellanprodukter användbara föreningar
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
FI893403A7 (sv) Förfarande för framställning av terapeutiskt användbara 1,4-dihydro-4-okso-3-kinolinkarboxylsyraderivat och additionsprodukter av dessa med vatten, syror och baser
NO862734L (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
FI885651A7 (sv) Förfarande för framställning av optiskt aktiva 3-desmetylmevalonsyraderivat samt mellanprodukter
FI870035A7 (sv) Förfarande för framställning av 2-arylpropionsyror
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
FI893883A7 (sv) Förfarande för framställning av terapeutiskt aktiva 7-tetrahydronaftyridin-6-fluor-1,4-dihydro-4-oxo-kinolin-3-karboxylsyror
FI902435A7 (sv) Förfarande för framställning av 2-asylalkanoinsyror
FI883997A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 2-fenyl-4-kinolinkarboxylsyror
FI881303A0 (sv) Förfarande för framställning av ibuprofen
FI906408L (sv) Förfarande för framställning av terapeutiskt användbara 2-aminopyrimidin-4-karboxamidderivat
FI884553A7 (sv) Analogiförfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridinderivat
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
FI880467A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
IL89535A0 (en) Process and novel intermediates for the preparation of 1-cyclopropyl-quinolone-carboxylic acids and their derivatives
NO177708C (no) Fremgangsmåte og mellomprodukter for fremstilling av oksoftalazinyl-eddiksyrer og analoger derav
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI921717A0 (sv) Förfarande för framställning av terapeutiskt användbara acyloxialkylestrar av 4-metoxi-10-(1-hydroxietyl)-11-oxo-1-azatricyklo/7.2.0.03,8/-undek-2-en-2-karboxylsyror
NO177712C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk virksomme alkylfosfonoseriner
ZA891534B (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
FI892946A7 (sv) Förfarande för framställning av nya terapeutiskt användbara 2,3,4,5-tetrahydro-1H-3-bensazepinderivat
FI890477L (sv) Förfarande för framställning av terapeutiskt användbar 2,5-diamino-6-fluorhexansyra och dess salter
FI893677L (sv) Förfarande för framställning av terapeutiskt användbara 6-fluor-3,5-dihydroxikarboxylsyror och deras derivat

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT